Eikon Therapeutics - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥470,994.11 -6.95%
以太坊 ¥13,840.57 -8.08%
币安币 ¥4,538.80 -8.89%
Optimism ¥1.27 -17.86%
Arbitrum ¥0.79 -12.63%
Solana ¥571.03 -12.78%
Polygon ¥1.56 +2.77%
Cosmos ¥13.10 -9.63%
Avalanche ¥60.76 -11.70%

比特币 ¥470,994.11 -6.95%
以太坊 ¥13,840.57 -8.08%
币安币 ¥4,538.80 -8.89%
Optimism ¥1.27 -17.86%
Arbitrum ¥0.79 -12.63%
Solana ¥571.03 -12.78%
Polygon ¥1.56 +2.77%
Cosmos ¥13.10 -9.63%
Avalanche ¥60.76 -11.70%

Eikon Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

1

18

Eikon Therapeutics is funded by 18 investors. Abu Dhabi Investment Authority and AME Cloud Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Abu Dhabi Investment Authority	-	Series B
AME Cloud Ventures	-	Series B
Canada Pension Plan Investment Board	-	Series B
E15 VC	-	Series B
EcoR1 Capital	-	Series B
Foresite Capital	-	Series B
General Catalyst	-	Series B
Harel Insurance Investments and Financial Services	-	Series B
Hartford HealthCare Endowment	-	Series B
Horizons Ventures	-	Series B
Innovation Endeavors	-	Series B
Lux Capital	-	Series B
Schroders Capital	-	Series B
Soros Capital Management	-	Series B
StepStone Group	-	Series B
T. Rowe Price	-	Series B
The Column Group	-	Series B
UC Investments	-	Series B